Search for Clinical Trials

S2210:  A Phase II Study of Neoadjuvant Carboplatin for Localized, High Risk Prostate Cancer With Germline BRCA1/2 MutationsThis phase II trial…
  • Cancer - All
  • Cancer - Prostate
  • Urology
NRG-BN013: Phase III Trial of Single Fraction Stereotactic Radiosurgery (SRS) Versus Fractionated SRS (FSRS) for Intact Brain MetastasesThis phase…
  • Cancer - All
  • Cancer - Brain
  • Cancer - Breast
  • Cancer - Colon/Rectal
  • Cancer - Kidney/Renal
  • Cancer - Lung
  • Cancer - Metastatic
S2209: A Phase III Randomized Trial for Newly Diagnosed Multiple Myeloma (NDMM) Patients Considered Frail or in a Subset of "Intermediate Fit"…
  • Cancer - All
  • Cancer - Hematology
  • Cancer - Myeloma
  • Hematology
A Randomized, Open-label, Phase 3 Study of Sacituzumab Govitecan Versus Treatment of Physician's Choice in Participants With Endometrial Cancer Who…
  • Cancer - All
  • Cancer - Cervical
  • Obstetrics and Gynecology
FORTE (NRG-CC005): Five or Ten Year Colonoscopy for 1-2 Non-Advanced Adenomatous PolypsThis trial examines colorectal cancer incidence in…
  • Cancer - All
  • Cancer - Colon/Rectal
  • Digestive System
A Single Arm Phase 4 Trial to Evaluate the Safety and Efficacy of Oral Fruquintinib in the Treatment of Refractory Metastatic Colorectal Cancer in…
  • Cancer - All
  • Cancer - Colon/Rectal
  • Digestive System
A Randomized Phase III Trial of Intravesical BCG veRsus Intravesical Docetaxel and GEmcitabine Treatment in BCG Naïve High Grade Non-Muscle Invasive…
  • Cancer - All
  • Cancer - Bladder
  • Urology
GLOFIT: A Phase Ib Study Evaluating the Safety, Efficacy, Pharmacokinetics, and Pharmacodynamics of Glofitamab in Combination With Gemcitabine Plus…
  • Cancer - All
  • Cancer - Hematology
  • Cancer - Lymphoma
  • Hematology
ROADS Trial: A Phase 3 Randomized Controlled Trial of Post-Surgical Stereotactic Radiotherapy (SRT) Versus Surgically Targeted Radiation Therapy (…
  • Brain/Spinal Cord/Nervous System
  • Cancer - All
  • Cancer - Brain
  • Neurology
S2303 PARAMMUNE: Randomized Phase II/III Trial of 2nd Line Nivolumab + Paclitaxel + Ramucirumab Versus Paclitaxel + Ramucirumab in Patients With PD-…
  • Cancer - All
  • Cancer - Gastric/Stomach
  • Digestive System
Back to topback-to-top